Ubs Asset Management Americas Inc 10x Genomics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 7,103,768 shares of TXG stock, worth $88.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,103,768
Previous 2,116,573
235.63%
Holding current value
$88.4 Million
Previous $30.4 Million
104.04%
% of portfolio
0.02%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding TXG
# of Institutions
302Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$160 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$79.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$66.9 Million0.03% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.36MShares$66.8 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.18B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...